Teicoplanin1*, a clinically useful glycopeptide antibiotic(2), is produced by Actinoplanes teichomyceticus as a complex of five main components, denoted factors A2-1 to A2-5, differing in the structure of their acyl side chain, which is linear in A2-1 and A2-3 and branched in the other components3). In a previous paper40 it was shown that the acyl moieties of the teicoplanin complexoriginate from stepwise shortening, through the usual /?-oxidation mechanism, of long chain fatty acids constituting the membrane of A. teichomyceticus cells(4).
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In fact there is a clear correspondence between the relative amount of a given fatty acid in the cell membrane and the amount of the teicoplanin component having as side chain the structurally related branched or linear acid. For instance, the amount of component A2-3, characterized by a linear C10 : 0 acyl chain, depends on the amountof oleic acid, whereas the production of A2-1, characterized by a linear C10: 1 acyl moiety, is entirely dependent on the addition of linoleate to the medium. This suggested the possibility of obtaining new members of the teicoplanin family by feeding A. teichomyceticus cultures with different eighteen carbons fatty acids having specific structural features. Our assumption was that these acids would be shortened (starting from the carboxyl group) to the proper length, i.e. ten carbons, and condensed to the core molecule.
Therefore, it could be predicted that addition of Gradient: %B: 0.5~55 linear in 32 minutes Flow: 1.5 ml/minute Detector: UV, 254nm. In addition to the peaks ofteicoplanin components, peaks were observed having relative retention times of about 0.80 (21.4 minutes) in the case of I, or of about 0.54 (12.0 minutes) in the case of II, with respect to that of the main component of teicoplanin, T-A2-2 (26 minutes). On the basis of peak areas, the filtrates contained about 1g of the new product in the case ofI or 7g in the case ofII.
The filtered broths were loaded on an affinity chromatography column prepared with. The first portion of the eluent (0.3 liter for I and 1.5 liters for II) was discarded and the fractions containing the product (10 fractions of 10ml for I and 8 fractions of 15ml for II) were separately collected. The two fractions of each product with the highest content of the new peak were pooled and ultra filtered on a 1000MW globular protein exclusion limit membrane and the retentate was lyophilized. The obtained products (20mg of I and 90mg of II), in which the newsubstances amounted to about 85% of the total lipoglycopeptide content, were considered sufficiently pure for structure determination.
Structure Determination of 4,7-Decadienoyl-teicopla- XHNMR spectra were recorded in DMSO-d6 solution at 500MHzwith a Bruker AM-500spectrometer equipped with an Aspect 3000 computer. COSYspectrum was obtained in the phase sensitive mode, double quantum filter.TOCSY experiment was based on Homonuclear Hartmann-Hann transfer with mixing by composite pulse cycle using inverse and phase sensitive mode (TPPI) optimized for long range couplings. *H NMRspectral assignments are reported in Table 1 . The attributions of the majority of the H-atoms were done on the basis of the 2-D experiments and by comparison with the known data for teicoplanin5'6).
Whereas the aglycone appears unchanged, differences are observed in the acyl moiety. The terminal group of the aliphatic chain is a CH3, as shown by a triplet at 0.90ppm. This CH3 is attached to a CH2shown by a multiplet at 1.99ppm which, as deduced from the COSYspectrum, is near an ethylenic double bond on the basis of its chemical shift and its coupling to a proton, whose signal is at about 5.2 ppm. Furthermore a CH2 indicated by a multiplet at 2.65 ppm must be placed between this double bond and a second double bond. Again, on the basis of coupling and chemical shift criteria, a CH2 at 2.08 ppm is placed between the second double bond and the CH2at 249 ppm, which is in the a position with respect to the amidic C=O. The XHNMRand COSYresults are thus in accordance with a teicoplanin-like molecule, with the in Table 2 . Whereas the aglycone portion of the molecule appears unchanged, differences are observed in the acyl moiety. The aliphatic chain is linear as the terminal group is a CH3 which gives rise to a triplet at 0.85ppm in the XHNMRspectrum. The integral values for the *H NMRsignals of the acyl chain fit a decanoyl chain. In the 1H-1H COSYspectrum a signal at 1.46ppm due to the CH2which is in beta position to the carbonyl of the acyl chain shows a coupling with the adjacent CH2 in alpha to the acyl carbonyl and also with a proton attributable to a CH-OHgroup, on the basis of the chemical shift value of 3.25ppm. The CH-OHin turn appears to be coupled with another CH2whose signal is located at 1.25ppm, in the region of the remaining CH2 of the chain. The XH NMRand COSY results are thus in accordance with a teicoplanin-like molecule,
where the normal acyl chain is constituted by a 4-OH decanoic group. It was observed that the complexobtained after the addition of Linseed oil to the fermentation mediumis modified in composition with respect to the standard teicoplanin complex. In particular, by HPLCanalysis, in addition to the formation of I, an increase has been noticed in the amounts of components TA-2-1 and TA-2-3, relatively to component TA-2-2. This is explained by the presence in Linseed oil triglyceride of 20% linoleic acid and 25% oleic acid, which are already known4) to give origin to TA-2-1 and TA-2-3, re-spectively. On the contrary, the composition of teicoplanin complex did not change after addition of Castor oil but, in addition to the newpeak corresponing to II, some small peaks have been noticed in the HPLCprofile due to the presence of other fatty acids in Castor oil. Both in the cases (addition of Linseed oil or Castor oil), the formation of the new products I or H did not depress the amountof teicoplanin complexproduced. 
